Effects of Sitagliptin on Postprandial Lipemia in Men With Type 2 Diabetes

NCT00660075 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus
Postprandial Lipemia

Interventions

DRUG: Sitagliptin
DRUG: Placebo

Sponsor

Laval University

Collaborators

[object Object]